Adage Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $95.2M | Buy |
|
|||||
|
2022
Q3 | $72.1M | Sell |
|
|||||
|
2022
Q2 | $114M | Sell |
|
|||||
|
2022
Q1 | $114M | Sell |
|
|||||
|
2021
Q4 | $165M | Buy |
|
|||||
|
2021
Q3 | $30.5M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $36.8M | Sell |
|
|||||
|
2020
Q2 | $110M | Buy |
|
|||||
|
2020
Q1 | $28.3M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $7.46M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $61.1M | Hold |
|
|||||
|
2017
Q1 | $59.1M | Buy |
|
|||||
|
2016
Q4 | $55.5M | Buy |
|
|||||
|
2016
Q3 | $57.8M | Sell |
|
|||||
|
2016
Q2 | $77.8M | Sell |
|
|||||
|
2016
Q1 | $86.8M | Buy |
|
|||||
|
2015
Q4 | $26.5M | Sell |
|
|||||
|
2015
Q3 | $39.7M | Sell |
|
|||||
|
2015
Q2 | $58.4M | Buy |
|
|||||
|
2015
Q1 | $23.4M | Buy |
|